MCO
71
-2
EBAY
39
-4
YUM
42
-3
KR
50
-2
NI
67
-3
MSFT
54
-3
EW
55
-2
CL
47
-3
GOOG
75
-6
STI
44
32
T
33
-3
PFG
28
-3
EL
25
-2
WY
34
-3
CCL
57
-3
GRMN
52
-3
TAP
51
-2
EQR
36
-3
KSS
39
-3
WHR
57
-2
MCO
71
-2
EBAY
39
-4
YUM
42
-3
KR
50
-2
NI
67
-3
MSFT
54
-3
EW
55
-2
CL
47
-3
GOOG
75
-6
STI
44
32
T
33
-3
PFG
28
-3
EL
25
-2
WY
34
-3
CCL
57
-3
GRMN
52
-3
TAP
51
-2
EQR
36
-3
KSS
39
-3
WHR
57
-2
Financhill
Back

CytoMed Therapeutics 10K Form

Buy
84

GDTC
CytoMed Therapeutics

Last Price:
$2.84
Seasonality Move:
-47.74%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GDTC News And Ratings

See the #1 stock for the next 7 days that we like better than GDTC

GDTC Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.65
Price / Book: 4.45

Profitability

EPS (TTM): -0.19340
Net Income (TTM): $-2.3M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

CytoMed Therapeutics Earnings Forecast

Key CytoMed Therapeutics Financial Ratios

  • The Interest Expense is -1.24% of Operating Income.
  • Per Share Earnings over the last 4 years have been positive in 0 years.

CytoMed Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: GDTC
Website: w2.cytomed.sg

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GDTC Technical Analysis vs Fundamental Analysis

Buy
84
CytoMed Therapeutics (GDTC) is a Buy

Is CytoMed Therapeutics a Buy or a Sell?